Outcomes following extended thoracic endovascular aortic repair for Type B aortic dissection from the global registry for endovascular aortic treatment.

0 CARDIAC & CARDIOVASCULAR SYSTEMS
Sara Allievi, Tim J Mandigers, Fred A Weaver, Ali Azizzadeh, Gabriele Piffaretti, Marc L Schermerhorn, Gregory A Magee, Dennis R Gable, Chiara Lomazzi, Santi Trimarchi
{"title":"Outcomes following extended thoracic endovascular aortic repair for Type B aortic dissection from the global registry for endovascular aortic treatment.","authors":"Sara Allievi, Tim J Mandigers, Fred A Weaver, Ali Azizzadeh, Gabriele Piffaretti, Marc L Schermerhorn, Gregory A Magee, Dennis R Gable, Chiara Lomazzi, Santi Trimarchi","doi":"10.1093/icvts/ivaf156","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>This study evaluated the short- to longer-term safety and efficacy of extended thoracic endovascular aortic repair for Type B aortic dissection.</p><p><strong>Methods: </strong>We identified acute and subacute Type B dissection between 2010 and 2016 in the Global Registry for Endovascular Aortic Treatment. We stratified the population based on treatment extent: 'non-extended' (1 stent graft deployed), 'extended' (>1 stent graft deployed). Our primary outcomes were in-hospital spinal cord ischaemia and mortality. Secondarily, we evaluated procedure-related complications (endoleak, migration, fracture, compression, reinterventions), sac dynamics, rupture, and all-cause mortality at 1 and 5 years. Sensitivity analysis was performed in patients without prior aortic procedures.</p><p><strong>Results: </strong>Of 170 procedures, 78 (46%) were extended (median 2 [range 2-5] stent-grafts). Extended and non-extended treatment had similar rates of complicated presentations (53% vs 64%; P = 0.13). Compared with non-extended treatment, extended treatment had similar in-hospital rates of spinal cord ischaemia (2.6% vs 2.2%; P = 1) and mortality (2.6% vs 2.2%, P = 1). Additionally, extended treatment had not statistically different sac expansion rates, (1 year: 14% vs 23%, P =0.80; 5 years: 16% vs 32%, P=0.29) and rupture risk (1 year: 1.3% vs 3.3%, P = 0.63), similar procedure-related complications (endoleak, migration, fracture, compression, reinterventions; all P > 0.05) and all-cause mortality (1 year: 10% vs 7.6%, P=0.54; 5 years: 19% vs 21%, P=0.82). All outcomes remained similar on sensitivity analysis.</p><p><strong>Conclusions: </strong>Our findings suggest that extended treatment for Type B aortic dissection may be associated with similar procedure-related risks and complications. Future larger studies are needed to define who might benefit from an extended treatment and further optimize patient-specific treatment for aortic dissection.</p>","PeriodicalId":73406,"journal":{"name":"Interdisciplinary cardiovascular and thoracic surgery","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12282756/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Interdisciplinary cardiovascular and thoracic surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/icvts/ivaf156","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"0","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: This study evaluated the short- to longer-term safety and efficacy of extended thoracic endovascular aortic repair for Type B aortic dissection.

Methods: We identified acute and subacute Type B dissection between 2010 and 2016 in the Global Registry for Endovascular Aortic Treatment. We stratified the population based on treatment extent: 'non-extended' (1 stent graft deployed), 'extended' (>1 stent graft deployed). Our primary outcomes were in-hospital spinal cord ischaemia and mortality. Secondarily, we evaluated procedure-related complications (endoleak, migration, fracture, compression, reinterventions), sac dynamics, rupture, and all-cause mortality at 1 and 5 years. Sensitivity analysis was performed in patients without prior aortic procedures.

Results: Of 170 procedures, 78 (46%) were extended (median 2 [range 2-5] stent-grafts). Extended and non-extended treatment had similar rates of complicated presentations (53% vs 64%; P = 0.13). Compared with non-extended treatment, extended treatment had similar in-hospital rates of spinal cord ischaemia (2.6% vs 2.2%; P = 1) and mortality (2.6% vs 2.2%, P = 1). Additionally, extended treatment had not statistically different sac expansion rates, (1 year: 14% vs 23%, P =0.80; 5 years: 16% vs 32%, P=0.29) and rupture risk (1 year: 1.3% vs 3.3%, P = 0.63), similar procedure-related complications (endoleak, migration, fracture, compression, reinterventions; all P > 0.05) and all-cause mortality (1 year: 10% vs 7.6%, P=0.54; 5 years: 19% vs 21%, P=0.82). All outcomes remained similar on sensitivity analysis.

Conclusions: Our findings suggest that extended treatment for Type B aortic dissection may be associated with similar procedure-related risks and complications. Future larger studies are needed to define who might benefit from an extended treatment and further optimize patient-specific treatment for aortic dissection.

Abstract Image

Abstract Image

Abstract Image

从全球登记的血管内主动脉治疗来看,扩展胸段血管内主动脉修复治疗b型主动脉夹层的结果。
目的:本研究评估了胸椎扩展血管内主动脉修复术治疗B型主动脉夹层的短期和长期安全性和有效性。方法:我们在2010-2016年血管内主动脉治疗全球注册表中确定了急性和亚急性B型夹层。我们根据治疗程度对人群进行分层:“非扩展”(部署1个支架),“扩展”(部署1个支架)。我们的主要结局是院内脊髓缺血和死亡率。其次,我们评估了手术相关的并发症(内漏、移位、骨折、压迫、再干预)、囊动力学、破裂和1年和5年的全因死亡率。对未做过主动脉手术的患者进行敏感性分析。结果:在170例手术中,78例(46%)扩展了支架移植物(中位2例[范围,2-5])。延长治疗和非延长治疗的复杂症状发生率相似(53% vs 64%;p = 0.13)。与非延长治疗组相比,延长治疗组的脊髓损伤住院率相似(2.6% vs 2.2%;P = 1)和死亡率(2.6% vs 2.2%;p = 1)。此外,延长治疗的囊扩张率无统计学差异(1年:14% vs 23%;p = 0.80;5年:16% vs 32%;P = 0.29),破裂风险(1年:1.3% vs 3.3%;P = 0.63),类似的手术相关并发症(内漏、移位、骨折、压迫、再干预;(p < 0.05)和全因死亡率(1年:10% vs 7.6%;p = 0.54;5年:19% vs 21%;p = 0.82)。所有结果在敏感性分析上保持相似。结论:我们的研究结果表明,B型主动脉夹层的延长治疗可能与类似的手术相关风险和并发症有关。未来需要更大规模的研究来确定谁可能从延长治疗中受益,并进一步优化针对主动脉夹层的患者特异性治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信